Pacira BioSciencesPCRX
那斯達克 · USD
23.75
+0.33
(+1.41%)
盤中 06/11 10:50 (UTC+8)
06/11 10:50 (UTC+8)
Pacira BioSciencesPCRX
23.75
+0.33
(+1.41%)
財務數據
損益表
- 1.81
- 1.67
- 1.78
- 1.69
- 1.87
- 1.69
- 1.81
- 1.80
- 1.97
- 1.77
- 10.56
- -7.79
- 6.53
- -5.31
- 11.08
- -9.79
- 7.21
- -0.87
- 9.67
- -9.90
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2026/Q1 | 2025/Q4 | 2025/Q3 | 2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | 2023/Q4 | |
營業收入淨額 | 177,376 | 196,873 | 179,516 | 181,099 | 168,923 | 187,253 | 168,573 | 178,023 | 167,117 | 181,244 |
營業成本 | 36,413 | 40,299 | 34,278 | 40,866 | 34,306 | 39,886 | 38,864 | 44,262 | 47,416 | 47,692 |
營業毛利 | 140,963 | 156,574 | 145,238 | 140,233 | 134,617 | 147,367 | 129,709 | 133,761 | 119,701 | 133,552 |
營業費用 | 134,061 | 154,234 | 138,876 | 131,734 | - | 122,663 | 269,236 | 105,521 | 106,489 | 100,384 |
研發費用 | 28,072 | 37,453 | 25,966 | 28,551 | 25,342 | 23,897 | 19,104 | 20,338 | 18,238 | 19,463 |
推銷及管理費用 | 91,667 | 101,608 | 91,797 | 82,391 | 86,776 | 79,614 | 74,333 | 68,126 | 72,026 | 65,801 |
非經常性項目費用 | - | 851 | 6,791 | 6,470 | 6,187 | 4,830 | 161,477 | 2,735 | 1,903 | 798 |
其他營業費用 | 14,322 | 14,322 | 14,322 | 14,322 | 14,322 | 14,322 | 14,322 | 14,322 | 14,322 | 14,322 |
營業利益 | 6,902 | 2,340 | 6,362 | 8,499 | 1,990 | 24,704 | -139,527 | 28,240 | 13,212 | 33,168 |
其他收入及費用 | 1,795 | 2,123 | 7,441 | -5,731 | 11,296 | 5,502 | 5,360 | 12,228 | 3,744 | 3,940 |
利息費用 | 3,699 | 3,892 | 4,279 | 4,695 | 4,580 | 4,680 | 4,689 | 3,884 | 3,316 | 3,388 |
稅前純益 | 4,998 | 571 | 9,524 | -1,927 | 8,706 | 25,526 | -138,856 | 36,584 | 13,640 | 33,720 |
所得稅 | 2,082 | -1,066 | 4,092 | 2,920 | 3,894 | 9,485 | 4,610 | 17,698 | 4,661 | 8,850 |
稅後純益 | 2,916 | 1,637 | 5,432 | -4,847 | 4,812 | 16,041 | -143,466 | 18,886 | 8,979 | 24,870 |
基本每股稅後盈餘(元) | 0.07 | 0.04 | 0.12 | -0.11 | 0.10 | 0.35 | -3.11 | 0.41 | 0.19 | - |
稀釋每股稅後盈餘(元) | 0.07 | 0.04 | 0.12 | -0.11 | 0.10 | 0.35 | -3.08 | 0.39 | 0.19 | 0.52 |
基本平均股數(千股) | 40461.00 | 42491.00 | 44038.00 | 45459.00 | 46275.00 | 46171.00 | 46134.00 | 46174.00 | 46499.00 | - |
稀釋平均股數(千股) | 40910.00 | 42981.00 | 44459.00 | 45459.00 | 46526.00 | 49036.00 | 46134.00 | 50539.00 | 52193.00 | - |
還原基本每股稅後盈餘(元) | 0.07 | 0.04 | 0.12 | -0.11 | 0.10 | 0.35 | -3.11 | 0.41 | 0.19 | - |
還原稀釋每股稅後盈餘(元) | 0.07 | 0.04 | 0.12 | -0.11 | 0.10 | 0.35 | -3.08 | 0.39 | 0.19 | 0.52 |
還原基本平均股數(千股) | 40,461 | 42,491 | 44,038 | 45,459 | 46,275 | 46,171 | 46,134 | 46,174 | 46,499 | - |
還原稀釋平均股數(千股) | 40,910 | 42,981 | 44,459 | 45,459 | 46,526 | 49,036 | 46,134 | 50,539 | 52,193 | - |
EBITDA(千元) | 30,035 | 21,454 | 35,676 | 32,872 | 35,321 | 52,317 | -113,051 | 60,117 | 36,087 | 56,302 |